Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-22T05:17:10.005Z Has data issue: false hasContentIssue false

Medications to Treat Epilepsy

from Section 2 - Medication Adverse Effects

Published online by Cambridge University Press:  30 May 2019

Alan B. Ettinger
Affiliation:
Safe Passage Diagnostics, New York
Deborah M. Weisbrot
Affiliation:
State University of New York, Stony Brook
Casey E. Gallimore
Affiliation:
University of Wisconsin
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Briviact (brivaracetam) package insert. Smyrna, GA: UCB, Inc.; Mar 2016.Google Scholar
Aptiom (eslicarbazepine acetate) package insert. Marlborough, MA: Sunovion Pharmaceuticals Inc.; Sep 2016.Google Scholar
Tegretol (carbamazepine) package insert. East Hanover, NJ: Novartis Pharmaceuticals Corporation; Jan 2014.Google Scholar
Trileptal (oxcarbazepine) package insert. East Hanover, NJ: Novartis Pharmaceuticals Corporation; April 2017.Google Scholar
Glauser, TA, Cnaan, A, Shinnar, S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months. Epilepsia. 2013; 51: 141–55.Google Scholar
Zarontin (ethosuximide capsule) package insert. New York, NY: Parke-Davis Div of Pfizer Inc.; May 2016.Google Scholar
Felbatol (felbamate tablet) package insert. Somerset, NJ: Meda Pharmaceuticals Inc.; July 2011.Google Scholar
Pellock, JM, Faught, E, Leppik, IE, Shinnar, S, Zupanc, ML. Felbamate: Consensus of current clinical experience. Epilepsy Res. 2006; 71: 89101.Google Scholar
Horizant (gabapentin enacarbil tablet, extended release) package insert. Atlanta, GA: Arbor Pharmaceuticals; Oct 2016.Google Scholar
Neurontin (gabapentin capsule) package insert. New York, NY: Parke-Davis Div of Pfizer Inc; Mar 2017.Google Scholar
Vimpat (lacosamide) package insert. Smyrna, GA: UCB, Inc.; Mar 2017.Google Scholar
Lamictal (lamotrigine tablet) package insert. Research Triangle Park, NC: GlaxoSmithKline LLC; May 2016.Google Scholar
Keppra (levetiracetam tablet) package insert. Smyrna, GA: UCB Farchim SA; April 2010.Google Scholar
Verrotti, A, Prezioso, G, Di Sabatino, F, et al. The adverse event profile of levetiracetam: A meta-analysis on children and adults. Seizure. 2015; 31: 4955.CrossRefGoogle ScholarPubMed
Ettinger, AB, LoPresti, A, Yang, H, et al. Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel. Epilepsia. 2015; 56: 1252–63.Google Scholar
Fycompa® (perampanel tablet) package insert. Woodcliff Lake, NJ: Eisai Inc.; April 2016.Google Scholar
Dilantin (phenytoin sodium capsule, extended release) package insert. New York, NY: Parke-Davis Div of Pfizer Inc; Feb 2017.Google Scholar
Lyrica (pregabalin capsule) package insert. New York, NY: Parke-Davis Div of Pfizer Inc; Jan 2017.Google Scholar
Toth, C. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf. 2014; 5: 3856.Google Scholar
Banzel (rufinamide tablet, film coated) package insert. Woodcliff Lake, NJ: Eisai Inc.; Jun 2015.Google Scholar
Gabitril (tiagabine hydrochloride tablet, film coated) package insert. North Wales, PA: Cephalon, Inc.; Aug 2016.Google Scholar
Topamax (topiramate tablet, coated) package insert. Titusville, NJ: Janssen Pharmaceuticals, Inc.; May 2017.Google Scholar
Depakote (divalproex sodium tablet, delayed release) package insert. North Chicago, IL: AbbVie Inc.; May 2017.Google Scholar
Nanau, R, Neuman, MG. Adverse drug reactions induced by valproic acid. Clin Biochem. 2013; 46: 1323–38.Google Scholar
Ferrie, CD, Robinson, RO, Panayiotopoulos, CP. Psychotic and severe behavioural reactions with vigabatrin: a review. Acta Neurol Scand. 1996; 93(1): 18.CrossRefGoogle ScholarPubMed
Vigabatrin (vigabatrin tablet, film coated) package insert. Deerfield, IL: Lundbeck Pharmaceuticals LLC; April 2017.Google Scholar
Verrotti, A, Loiacono, G, Di Sabatino, F, Zaccara, G. The adverse event profile of zonisamide: a meta-analysis. Acta Neurol Scand. 2013; 128(5): 297304.Google ScholarPubMed
Zonegran (zonisamide capsule) package insert. St. Michael, Barbados: Concordia Pharmaceuticals Inc.; April 2016.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×